Drawing for VYALEV

USPTO serial 88640320

VYALEV

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCCARTHY, BRIDGET ANN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VYALEV?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cheryl A. Withycombe

Cheryl A. Withycombe AbbVie Inc.2525 Dupont DriveAND-250CIrvine, CA 92612

Goods and services

ClassDescriptionStatusFirst use
005Prescription-only pharmaceutical preparations and substances for the treatment of neurological diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 26, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 25, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 24, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 23, 2023EX5GSOU EXTENSION 5 GRANTED—
Mar 21, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 8, 2023EXT5SOU EXTENSION 5 FILED—
Mar 8, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 22, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2022EX4GSOU EXTENSION 4 GRANTED—
Nov 18, 2022EXT4SOU EXTENSION 4 FILED—
Nov 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 10, 2022EX3GSOU EXTENSION 3 GRANTED—
May 10, 2022EXT3SOU EXTENSION 3 FILED—
May 10, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 19, 2021EX2GSOU EXTENSION 2 GRANTED—
Nov 19, 2021EXT2SOU EXTENSION 2 FILED—
Nov 19, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 30, 2021DOCKASSIGNED TO EXAMINER—
May 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 20, 2021EX1GSOU EXTENSION 1 GRANTED—
May 20, 2021EXT1SOU EXTENSION 1 FILED—
May 20, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 19, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 19, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 24, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 9, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
Oct 9, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Oct 9, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Mar 11, 2020OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 11, 2020OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Feb 18, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 18, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 16, 2020ALIEASSIGNED TO LIE—
Jan 13, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 8, 2020DOCKASSIGNED TO EXAMINER—
Oct 7, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 7, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance